This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier To Showcase Broad Set Of Solutions For Improved Care And Better Patient Outcomes At HIMSS14

Stocks in this article: ENLRENRUK

PHILADELPHIA, February 19, 2014 /PRNewswire/ --

Integrated clinical solutions suite from Elsevier on display at annual meeting to help healthcare providers 'Seize Today, Control Tomorrow'

Elsevier, a world-leading provider of scientific, technical and medical information products and services, will demonstrate its integrated clinical solutions suite at booth #6352 at the Healthcare Information and Management Systems Society (HIMSS14) annual meeting in Orlando, FL, February 23-27.

"Clinical and operational excellence are constantly top-of-mind for hospital CIOs, CMIOs and CNIOs amid the ever-evolving healthcare landscape," said Jay Katzen, President of Elsevier Clinical Solutions. "Our integrated clinical solutions help these hospital executives effectively manage the many moving parts needed to provide quality care and run a successful business.

"From evidence-based clinical information to clinical practice transformation and patient education, Elsevier offers a wide range of solutions to meet the needs of clinical leaders now and in the future," Katzen said.

Addressing the needs of hospital executives, Elsevier's integrated suite of clinical solutions includes:

  • Workflow & Decision Support
  • Patient Engagement
  • Clinical Reference
  • Drug Reference
  • Performance Management

Elsevier will extend its involvement at HIMSS14 through a number of events during the conference, including:

  • Innovation Symposium: Jonathan Teich, MD, PhD, Elsevier's Chief Medical Informatics Officer, will co-chair the Innovation Symposium, "Health IT innovation: From Concept to Results," all day on Sunday, February 23, in Room 300. He will give the introductory presentation and moderate several sessions on the symposium agenda.
  • CDS Presentation: Dr. Teich will also present on "Improving Outcomes with CDS #1" at the Physicians' Symposium, from 1:45-2:15 pm, Sunday, February 23, at Room 224.
  • Education Session: Michelle Troseth, MSN, RN, DPNAP, FAAN, and Elsevier's Chief Professional Practice Officer, will moderate at Education Session 10 on "Revolutionizing and Innovating Leaders: Driving Healthcare for the Future" at 10-11 am, Monday, February 24, in Room 300.
  • Connected Patient Learning Gallery: Elsevier Clinical Solutions will showcase its patient engagement solutions in Hall A / Booth 2383, and feature speaking sessions by Ann Fury, RN, MBA, NC-BC of Brigham and Women's Hospital on Tuesday, February 24, from 2:45-3:15 pm and Wednesday, February 25 from 11:30 am - 12 pm.
  • Special CPM Toast: Elsevier will welcome its CPM customers with a special reception and toast at its booth, #6352, from 5-6 pm, Monday, February 24, in recognition of the recent KLAS designation of Elsevier CPM as a Category Leader in the "CDS - Order Sets and Care Plans" category.
  • TIGER Reception: As TIGER Board Co-Chair, Troseth will also make introductions at the TIGER Meet & Greet reception from 4-5:30 pm, Tuesday, February 25, in Gallery 333B.
  • Calling All Thought Leaders: Elsevier Clinical Solutions will encourage healthcare thought leaders at HIMSS14 to communicate their perspectives on some of the industry's most important topics and challenges at its real-time interactive booth experience. A touchscreen kiosk will enable attendees to provide input and insights related to a set of thought-provoking questions, and each participant's contribution will be displayed on a large screen at the booth. Participants can win prizes.
  • eHI Reception: Elsevier Clinical Solutions is sponsoring the eHealth Initiative " Mardi Gras Cocktail Reception" on Monday, February 24, from 6-8 pm, at the Rosen Centre Hotel, Salon 16 (access from the convention center via sky bridge). RSVP here.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Christopher Capot Director, Corporate Relations Elsevier +1-917-704-5174 (mobile) +1-212-633-3164 c.capot@elsevier.com

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,103.24 +128.93 0.76%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,539.0240 -10.2020 -0.22%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs